Trials / Completed
CompletedNCT00224003
Study of the Safety and Efficacy of Ferrlecit® Maintenance Dosing in Pediatric Hemodialysis Patients
Open-Label, Multi-Center Study of the Safety and Efficacy of Ferrlecit® in the Maintenance of Iron Stores in Pediatric Hemodialysis Patients Receiving Epoetin
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 23 (actual)
- Sponsor
- Watson Pharmaceuticals · Industry
- Sex
- All
- Age
- 2 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
A phase 4 clinical investigation in iron-replete pediatric hemodialysis patients, whose legal guardian had provided signed informed consent, and who had satisfied the inclusion and exclusion criteria of the study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sodium Ferric Gluconate Complex in Sucrose. |
Timeline
- Start date
- 2003-04-01
- Primary completion
- 2004-03-01
- Completion
- 2005-02-01
- First posted
- 2005-09-22
- Last updated
- 2009-09-28
- Results posted
- 2009-09-28
Locations
10 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00224003. Inclusion in this directory is not an endorsement.